Median Technologies (XPAR:ALMDT) Common Stock: €1.84 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALMDT Median Technologies XPAR:ALMDT
49 GF Score
Price €4.09
GF Value €1.72
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Median Technologies Common Stock?

Median Technologies XPAR:ALMDT +0.25% 49 Common Stock is €1.84 Mil as of Dec. 2025. GuruFocus rates XPAR:ALMDT with a GF Score™ of 49/100 and a GF Value™ of €1.72 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Median Technologies's quarterly common stock increased from Dec. 2024 (€0.93 Mil) to Jun. 2025 (€0.98 Mil) and increased from Jun. 2025 (€0.98 Mil) to Dec. 2025 (€1.84 Mil).

Median Technologies's annual common stock increased from Dec. 2023 (€0.92 Mil) to Dec. 2024 (€0.93 Mil) and increased from Dec. 2024 (€0.93 Mil) to Dec. 2025 (€1.84 Mil).

Median Technologies Common Stock Historical Data

* Premium members only.

The historical data trend for Median Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Technologies Common Stock Chart

Median Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.79 0.92 0.93 1.84

Median Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.92 0.93 0.98 1.84
XPAR:ALMDT
49GF Score
Median Technologies XPAR:ALMDT
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Median Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €1.84 Mil mean?
Median Technologies (XPAR:ALMDT) has a Common Stock of €1.84 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Median Technologies and its competitors.
Is Median Technologies' Common Stock too high?
Median Technologies' current Common Stock is €1.84 Mil. Overall, Median Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Median Technologies' Common Stock compare to ABT and SYK?
Median Technologies' Common Stock of €1.84 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Median Technologies and its competitors. Median Technologies's current Common Stock is €1.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Median Technologies stock overvalued right now?
Based on GuruFocus' analysis, Median Technologies (XPAR:ALMDT) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.72, compared to a current price of €4.09 — trading 137.8% above its estimated fair value. The current Common Stock is €1.84 Mil. Median Technologies' overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Median Technologies (XPAR:ALMDT), the current Common Stock is €1.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Median Technologies (XPAR:ALMDT) Overvalued in 2026?

Based on GuruFocus' analysis, Median Technologies stock appears to be overvalued. The current stock price of €4.09 is trading 137.8% above its estimated GF Value™ of €1.72. GuruFocus considers Median Technologies to be Significantly Overvalued.

Key valuation signals for XPAR:ALMDT:

  • Common Stock: €1.84 Mil
  • GF Value™: €1.72 vs. price of €4.09 (137.8% above fair value)
  • GF Score™: 49/100 with 8 warning signs

No single metric tells the full story. See the XPAR:ALMDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Median Technologies Business Description

Other Exchanges 4ZG:Germany
Address 1800 Route Des Cretes, Les Deux Arcs, Building B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
49GF Score

Get the complete analysis for XPAR:ALMDT

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.09
Price
€1.72
GF Value